肺良性转移性平滑肌瘤1例报告及文献复习

doi:10.13481/j.1671-587X.20230127

Abstract

Abstract:

Objective To explore the feasibility of the treatment strategy of no treatment and only regular follow-up for the patient with asymptomatic postmenopausal pulmonary benign metastasizing leiomyomat（PBML）， and to provide a reference for the diagnosis， treatment， and prognosis of the disease. Methods The clinical characteristics， examination results， and follow-up results of a patient with PBML were analyzed retrospectively， and the pathogenesis and treatment measures were discussed in combination with the literature review. Results The female patient， 52 years old，was admitted to the hospital due to the physical examination of multiple nodules in both lungs， and previously underwent total hysterectomy for multiple uterine leiomyomas. There were no obvious pulmonary signs，and imaging examination showed multiple round nodular hyperdense shadows in both lungs. Percutaneous biopsy of pulmonary nodules was performed under the guidance of computed tomography （CT） in the left lung. The pathological diagnosis was PBML， and estrogen receptor（ER） and progesterone receptor（PR） were positive. The patient’s sex hormone level was in menopause，so no treatment was given， and regular imaging examinations and follow-up were carried out. The CT follow-up at 5， 11， 20， and 34 months after percutaneous lung puncture showed that no obvious enlargement of bilateral pulmonary nodules was found， and no cough， wheezing and other discomfort symptoms were found at 41 months. Conclusion The asymptomatic female PBML patients with hormone levels in menopause may not be treated and only need the regular imaging follow-up.

Key words: Benign metastasizing leiomyoma, Uterine neoplasms, Neoplasm metastasis, Lung neoplasms

CLC Number:

R734.2

Mengshi MA,Peng CHEN,Zhongsen MA. Pulmonary benign metastasizing leiomyoma：A case report and literature review[J].Journal of Jilin University(Medicine Edition), 2023, 49(1): 203-208.

Figures/Tables 3

References 30

1	MAREDIA R， SNYDER B J， HARVEY L A， et al. Benign metastasizing leiomyoma in the lung［J］. RadioGraphics， 1998， 18（3）： 779-782.
2	ASUMU H， ESTRIN Y， MOHAMMED T L， et al. Benign metastasizing leiomyoma［J］. Curr Probl Diagn Radiol， 2017， 46（3）： 257-259.
3	SAADEH FABU， RIAIN C O， CORMACK C M，et al.Lung metastases from benign uterine leiomyoma： does 18-FDG-PET/CT have a role to play？［J］. Ir J Med Sci， 2019， 188（2）： 619-624.
4	许洁，温岩，孙晓艳. 良性转移性平滑肌瘤复发1例报告［J］. 吉林大学学报（医学版）， 2011， 37（5）： 958.
5	AZENE E M， GAI Q W， TABAR S P， et al. Metastasis of a histologically benign： appearing meningioma to the iliac bone［J］. J Clin Oncol， 2008， 26（28）： 4688-4690.
6	STEINER P E. Metastasizing fibroleiomyoma of the uterus： report of a case and review of the literature［J］. Am J Pathol， 1939， 15（1）： 89-110.7.
7	TUBBS W S， BROWN L R， BEABOUT J W， et al. Benign giant-cell tumor of bone with pulmonary metastases： clinical findings and radiologic appearance of metastases in 13 cases［J］. AJR Am J Roentgenol， 1992， 158（2）： 331-334.
8	BARNAŚ E， KSIĄŻEK M， RAŚ R， et al. Benign metastasizing leiomyoma： a review of current literature in respect to the time and type of previous gynecological surgery［J］. PLoS One， 2017， 12（4）： e0175875.
9	LOW H Y， ZHAO Y， HUANG K S， et al. Intravenous leiomyomatosis of the uterus： a clinicopathological analysis of nine cases and literature review［J］. Taiwan J Obstet Gynecol， 2017， 56（3）： 362-365.
10	MA G T， MIAO Q， LIU X R， et al.Different surgical strategies of patients with intravenous leiomyomatosis［J］. Medicine （Baltimore）， 2016， 95（37）： e4902.
11	LIN J， SONG X Y， LIU C R. Pelvic intravascular leiomyomatosis associated with benign pulmonary metastasizing leiomyoma： clinicopathologic， clonality， and copy number variance analysis［J］. Int J Gynecol Pathol， 2014， 33（2）： 140-145.
12	KOH D M， BURN P R， KING D M. Benign metastasizing leiomyoma with intracaval leiomyomatosis［J］.Br J Radiol，2000，73（868）：435-437.
13	YAMAZAKI K. CD10- and CD34-positive periglandular stromal cells in pulmonary benign metastasizing leiomyoma with metaplastic adenomyomatous glands： an ultrastructural and immunohistochemical study［J］. Virchows Arch， 2005， 446（3）： 270-277.
14	GAICHIES L， FABRE-MONPLAISIR L， FAUVET R，et al. Leiomyomatosis peritonealisis disseminata： two unusual cases with literature review［J］. J Gynecol Obstet Hum Reprod， 2018， 47（2）： 89-94.
15	TON R， KILIC G S， PHELPS J Y. A medical-legal review of power morcellation in the face of the recent FDA warning and litigation［J］. J Minim Invasive Gynecol， 2015， 22（4）： 564-572.
16	NUCCI M R， DRAPKIN R， DAL CIN P， et al. Distinctive cytogenetic profile in benign metastasizing leiomyoma： pathogenetic implications［J］. Am J Surg Pathol， 2007， 31（5）： 737-743.
17	JIANG J， HE M， HU X， et al. Deep sequencing reveals the molecular pathology characteristics between primary uterine leiomyoma and pulmonary benign metastasizing leiomyoma［J］. Clin Transl Oncol， 2018， 20（8）： 1080-1086.
18	KHAN M， FAISAL A， IBRAHIM H， et al. Pulmonary benign metastasizing leiomyoma： a case report［J］. Respir Med Case Rep， 2018， 24： 117-121.
19	KI E Y， HWANG S J， LEE K H， et al. Benign metastasizing leiomyoma of the lung［J］. World J Surg Oncol， 2013， 11（（3））： 279.
20	MAHMOUD M S， DESAI K， NEZHAT F R. Leiomyomas beyond the uterus； benign metastasizing leiomyomatosis with paraaortic metastasizing endometriosis and intravenous leiomyomatosis： a case series and review of the literature［J］. Arch Gynecol Obstet， 2015， 291（1）： 223-230.
21	PACHECO-RODRIGUEZ G， TAVEIRA-DASILVA A M， MOSS J. Benign metastasizing leiomyoma［J］. Clin Chest Med， 2016， 37（3）： 589-595.
22	PATTON K T， CHENG L， PAPAVERO V， et al. Benign metastasizing leiomyoma： clonality， telomere length and clinicopathologic analysis［J］. Mod Pathol， 2006， 19（1）： 130-140.
23	CHEN A P， SUN T， PU X H， et al. Concurrent pulmonary benign metastasizing leiomyoma and primary lung adenocarcinoma： a case report［J］. AME Case Rep， 2018， 2： 18.
24	REIN M S. Advances in uterine leiomyoma research： the progesterone hypothesis［J］. Environ Health Perspect， 2000， 108（）： 791-793.
25	BOAVIDA FERREIRA J， CABRERA R， SANTOS F，et al. Benign metastasizing leiomyomatosis to the skin and lungs， intravenous leiomyomatosis， and leiomyomatosis peritonealis disseminata： a series of five cases［J］. Oncologist， 2022， 27（1）： e89-e98.
26	FINDAKLY D， WANG J. Molecular profiling of benign metastasizing leiomyoma of the uterus revealing unique novel therapeutic targets［J］. Cureus， 2020，12（4）： e7701.
27	LEWIS E I， CHASON R J， DECHERNEY A H，et al. Novel hormone treatment of benign metastasizing leiomyoma： an analysis of five cases and literature review［J］. Fertil Steril， 2013， 99（7）： 2017-2024.
28	RADZIKOWSKA E， SZCZEPULSKA-WÓJCIK E， LANGFORT R， et al. Benign pulmonary metastasizing leiomyoma uteri. Case report and review of literature［J］. Pneumonol Alergol Pol， 2012， 80（6）： 560-564.
29	KHAN M， FAISAL A， IBRAHIM H， et al. Pulmonary benign metastasizing leiomyoma： a case report［J］. Respir Med Case Rep， 2018， 24： 117-121.
30	HOETZENECKER K， ANKERSMIT H J， AIGNER C，et al. Consequences of a wait-and-see strategy for benign metastasizing leiomyomatosis of the lung［J］. Ann Thorac Surg， 2009， 87（2）： 613-614.

[1]	Yang JIANG,Zhaowen PENG,Shujing YI,Hailing YOU,Gaofei FENG,Chuanbo LIU,Kaiwen HU. Argon-helium knife cryoablation in treatment of pulmonary mucoepidermoid carcinoma: A case report and literature review [J]. Journal of Jilin University(Medicine Edition), 2022, 48(4): 1040-1044.
[2]	Zhijuan WANG,Mingshu ZHANG,Liping YE. Effects of platelet-derived growth factor D on proliferation, migration and invasion of lung cancer H1299 cells through ERK signaling pathway and their mechanisms [J]. Journal of Jilin University(Medicine Edition), 2022, 48(4): 898-904.
[3]	Shuang MIAO,Na NI,Lijuan YANG,Yan WU,Xuelin LI,Hongliang DONG,Kaikai GONG. Synergistic inhibitory effect of aaptamine and cisplatin on cisplatin resistant human lung adenocarcinoma A549/DDP cells [J]. Journal of Jilin University(Medicine Edition), 2021, 47(1): 8-15.
[4]	Weiwei CHEN,Jiajia AN,Yan WU,Juanjuan DAI,Jing DU. Construction and identification of GLI1 eukaryotic expression vector and its effect on proliferation of lung cancer PC9 cells [J]. Journal of Jilin University(Medicine Edition), 2020, 46(6): 1150-1154.
[5]	ZHOU Ning, WU Rui, MA Zhenkai, CHEN Weiwei, LI Xuelin, GONG Kaikai, YANG Lijuan, DAI Juanjuan, WU Yan. Effects of down-regulation of ADAR1 expression on proliferation, migration and epithelial-mesenchymal transition of human lung cancer cells [J]. Journal of Jilin University(Medicine Edition), 2020, 46(04): 669-674.
[6]	ZHANG Shuangshuang, HE Wubin, SU Rongjian, DU Xiaoyuan. Effects of EZH2 inhibitor GSK126 on proliferation and apoptosis of lung adenocarcinoma cells [J]. Journal of Jilin University(Medicine Edition), 2020, 46(04): 786-791.
[7]	ZHOU Ning, GUO Jiwei, DAI Juanjuan, LI Xuelin, XI Sichuan, GONG Kaikai, WU Yan. Effect of YAP on proliferation and migration of non-small cell lung cancer cells [J]. Journal of Jilin University(Medicine Edition), 2019, 45(06): 1320-1326.
[8]	WANG Shangning, WANG Sisi, TIAN Shuyan, LI Jialin, LIU Wei. Early changes of peripheral blood lymphocyte subsets in patients with lung adenocarcinoma after single-port thoracoscopic lobectomy and their clinical significances [J]. Journal of Jilin University(Medicine Edition), 2019, 45(03): 606-613.
[9]	LEI Qingyan, WANG Ling, WANG Bowei, ZHANG Weiyang. Clinical diagnosis and prognosis analysis of patients with endometrial dedifferentiated carcinoma: A report of 12 cases [J]. Journal of Jilin University(Medicine Edition), 2019, 45(03): 688-691.
[10]	LIU Xiangliang, JI Wei, LI Li, ZHAO Yinghua, JIA Lin, WANG Zhiqiang, CHEN Xiao, LI Wei. Lung adenocarcinoma treated by Erlotinib HCL Tablets and chemotherapy combined with bevacizumab after drug resistance:A case report and literature review [J]. Journal of Jilin University Medicine Edition, 2017, 43(05): 1019-1024.
[11]	XIAO Yan, WANG Huan, WANG Shumin, GAO Ying. Lung cancer complicated with syndrome of inappropriate secretion of antidiuretic hormone:A report of 2 cases and literature review [J]. Journal of Jilin University Medicine Edition, 2017, 43(03): 643-645.
[12]	LI Xingxing, TAN Jingjin, JIANG Shan, WAHG Ke. Role of let-7 and HMGA2 in occurrence and development of lung cancer: Meta-analysis [J]. Journal of Jilin University Medicine Edition, 2016, 42(06): 1116-1125.
[13]	ZHENG Quanhui, WANG Na, SONG Tianjiao, CAO Qianwen, TIAN Yu, HAO Xiaohui, ZHANG Aihong. Changes of number of regulatory T cells and NK cells in tumor tissue and main immune organs of murine models of lung cancer and their significances [J]. Journal of Jilin University Medicine Edition, 2016, 42(04): 659-664.
[14]	ZAO Hang, WANG XU, LI WEI. Influence of single nucleotide polymorphisms of CDA in prognosis of advanced non-small cell lung cancer patients treated with gemcitabine [J]. Journal of Jilin University Medicine Edition, 2016, 42(02): 316-320.
[15]	CHENG Xin, MA Yanru, LIU Yimin, DANG Yonghong, XING Haiqun, HU Nan. Application of ¹⁸FDG PET/CT in diagnosis of ectopic ACTH syndrome induced by lung cancer [J]. Journal of Jilin University Medicine Edition, 2015, 41(06): 1275-1278.

Pulmonary benign metastasizing leiomyoma：A case report and literature review

RichHTML

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 3

References 30

Related Articles 15

Metrics

Comments

Recommended 0